Table 1 Characteristics of the grafts depending on the recipient’s and donor’s BMI, univariate analysis
| Â | Recipient BMI | Donor BMI | |||||||
|---|---|---|---|---|---|---|---|---|---|
|  | Underweight N = 41 (13%) | Normal weight N = 130 (43%) | Overweight/obesity N = 133 (44%) | p | Underweight, N = 10 (3.6%) | Normal weight, N = 128 (46%) | Overweight, N = 95 (34%) | Obesity, N = 46 (16%) | p |
Male gender, n (%) | 11 (27) | 72 (55) | 75 (56) | 0.002 | 6 (60) | 61 (48) | 56 (59) | 25 (54) | 0.38 |
Duration of MV, donor, med [IQR] | 2 [1, 4] | 2 [1, 3] | 2 [1, 3] | 0.75 | 2 [1–3] | 2 [1–3] | 2 [2–4] | 2 [1–3] | 0.21 |
PaO2/FiO2, donor, med [IQR] | 402 [350–470] | 380 [326–450] | 390 [334- 464] | 0.38 | 482 [401–499] | 425 [351–481] | 379 [326–446] | 345 [302–380] | < 0.001 |
Age, donor, med [IQR] | 51 [44–57] | 52 [35–62] | 54 [42–63] | 0.56 | 45 [27–50] | 49 [35–60] | 55 [47–65] | 55 [46–59] | 0.002 |
Tobbaco use, donor, n (%) | 18 (45) | 35 (28) | 65 (50) | 0.001 | 2 (20) | 52 (42) | 33 (35) | 20 (43) | 0.43 |
Transfusion, donor, n (%) | 11 (27) | 37 (29) | 33 (26) | 0.84 | 1 (10) | 38 (30) | 24 (26) | 8 (18) | 0.31 |